The deregulation of STIM1 and store operative calcium entry (SOCE) impaired aortic smooth muscle cells contractility in aortic medial degeneration.

BACKGROUND:  Micro-array analysis of clinical aortic samples suggested a potential role for STIM1 in the modulation of aortic medial degeneration (AMD), despite the uncertainty about STIM1 in normal aortic smooth muscle cells (ASMCs). Here, we aimed to explore changes in STIM1 expression in AMD, and the possible mechanisms. Methods: An AMD model was established using auto-delivery of angiotensin II into ApoE-/- mice. We assessed the effects of SKF96365, a STIM1 inhibitor, in AMD model and i n vitro  cultured ASMCs. Elastic van Gieson staining was used to visualize elastic fiber injury. Mitochondria changes were viewed by transmission electron microscopy. Cytoplasmic calcium was quantified by measuring fluo-4 staining in a flow cytometer. Mechanical stretching device was used to mimic stretching that ASMCs experience in vivo Cell apoptosis was determined by using Annexin V/propidium iodide (PI) staining. The expression of STIM1, contractile related proteins (α-smooth muscle actin [α-SMA], myosin light chain [MLC]), endoplasmic reticulum (ER) stress related proteins (CHOP, ATF-6) and smad2/3 were assessed by Western blotting, immunohistochemistry and immunofluorescence.

RESULTS: SKF96365 exacerbated aortic injury in the AMD model. SKF96365 reduced cytoplasmic calcium concentration in ASMCs, caused mitochondrial swelling and elevated the expression of ATF-6 and CHOP. SKF96365 decreased the expression of MLC and α-SMA in ASMCs, causing them to be vulnerable to mechanical stretch. SKF96365 suppressed smad2/3 activation after treatment with transforming growth factor β1 (TGFβ1). Conclusions: STIM1 is indispensable in ASMCs. Interfering with STIM1 exaggerated the AMD process by modulating the expression of contractile proteins, inducing ER stress in ASMCs.